Back to NewEdge Advisors, LLC NewEdge Advisors, LLC

PHARPHAR
4 quarters

Position history for NewEdge Advisors, LLCNewEdge Advisors, LLC's holdings in PHARMING GROUP NV

Yes. Newedge Group holds 187 shares of PHAR (Pharming Group), worth $2,596, as of its Q2 2026 13F filing. It reduced the position by 1,963 shares (-91.3%) from Q1 2026. Newedge Group has held PHAR since Q3 2025, across 4 quarterly 13F filings.

Current Value

$2,596

Current Shares

187

Total Value Change

-$1,075

Total Shares Change

-66

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
187
-91.3%
$2,5960.0%$13.89
0
2026-Q1
Decreased
2,150
-92.5%
$35,7770.0%$15.40
0
2025-Q4
Increased
28,868
+113x
$510,0970.0%$16.81
39
2025-Q3
New
253
-
$3,6710.0%$14.18
21

Other major holders of PHAR: MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC, MORGAN STANLEY, JANE STREET GROUP, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used